Concepedia

Rubén González del Río

RG

Statistics

Publications

8

Citations

350

H-Index

8

Active since

2015

Affiliations

GlaxoSmithKline (Spain)(Current)

University of British Columbia

Center for Discovery

Hackensack Meridian Health

Georgetown University

Rubén González del Río is an author at GlaxoSmithKline (Spain) specializing in medicinal chemistry, drug discovery, and medicine.

Top concepts

Publications per year

2015–2023

8

Publications

8

Repurposing clinically approved cephalosporins for tuberculosis therapy

Santiago Ramón‐García, Rubén González del Río, Angel Santos Villarejo et al. · Scientific Reports · 2016 · 87 citations · Full text

Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages

Flavia Sorrentino, Rubén González del Río, Xingji Zheng et al. · Antimicrobial Agents and Chemotherapy · 2015 · 75 citations · Full text

, , +23

Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs

Delia Blanco, Esther Pérez‐Herrán, Mónica Cacho et al. · Antimicrobial Agents and Chemotherapy · 2015 · 45 citations · Full text

Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery

María José Rebollo-López, Joël Lelièvre, Daniel Álvarez-Gómez et al. · PLoS ONE · 2015 · 45 citations · Full text

, , +19

A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Antimycobacterial Activity

Uday S. Ganapathy, Rubén González del Río, Mónica Cacho-Izquierdo et al. · Antimicrobial Agents and Chemotherapy · 2021 · 39 citations · Full text

1–5 of 8